MARATTO

article · Journal of Controlled Release

Drug-likeness defects drive carrier-free cyanine–PROTAC self-assembly for tumor-specific protein degradation

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Protein Degradation and Inhibitors
  • Click Chemistry and Applications
  • HER2/EGFR in Cancer Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.jconrel.2026.115217

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.